New biomarkers and targeted therapies are reshaping the management of kidney damage in autoimmune diseases like lupus and vasculitis. Experts at a Spanish medical meeting highlighted...
Beeline Medicines launches globally with $300M funding and Bristol Myers Squibb assets to develop precision therapies for autoimmune and inflammatory diseases. Led by Saqib Islam, it...